Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company is headquartered in Richmond, California.
| Revenue (TTM) | $12.80M |
| Gross Profit (TTM) | $6.84M |
| EBITDA | $-11.00M |
| Operating Margin | -119.70% |
| Return on Equity | -107.60% |
| Return on Assets | -33.60% |
| Revenue/Share (TTM) | $5.28 |
| Book Value | $2.54 |
| Price-to-Book | 20.20 |
| Price-to-Sales (TTM) | 3.29 |
| EV/Revenue | 3.995 |
| EV/EBITDA | 0.46 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -38.30% |
| Shares Outstanding | $3.56M |
| Float | $2.24M |
| % Insiders | 24.54% |
| % Institutions | 26.74% |
Volatility is currently contracting
DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced the appointment of Cenly Chen as Chief Executive Officer and a member of the Company's Board of Directors.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on EKSO and any ticker you trade — then tracks every position and per-strategy win rate.
